StockDuty ← Dashboard Aug 20, 2026 01:27 AM ET
SignalFDA/Bio

Merck (MRK) Posts First Successful Phase 3 Individualized mRNA Cancer Vaccine Result

First successful Phase 3 mRNA cancer vaccine result for Merck.

First successful Phase 3 mRNA cancer vaccine result for Merck.
Sources